Overview
RadNet Q3 revenue grows 13.4% yr/yr to $522.9 mln
Adjusted EPS for Q3 misses analyst expectations
Company revises full-year guidance upwards for revenue and EBITDA
Outlook
RadNet raises 2025 Imaging Center revenue guidance to $1.9 bln-$1.93 bln
Company increases 2025 Imaging Center adjusted EBITDA guidance to $276 mln-$284 mln
RadNet lifts 2025 Digital Health revenue guidance to $85 mln-$95 mln
Result Drivers
ADVANCED IMAGING - Strong growth in advanced imaging procedural volumes contributed to revenue increase
NEW CENTERS & JOINT VENTURES - New center openings and expansion of health system joint ventures supported revenue growth
DIGITAL HEALTH GROWTH - Digital Health segment revenue increased 51.6%, boosting overall company performance
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
$522.9 mln
Q3 Adjusted EPS
Miss
$0.20
$0.22 (7 Analysts)
Q3 EPS
$0.07
Q3 Net Income
$13.89 mln
Q3 Income from operations
$27.39 mln
Q3 Operating Expenses
$495.48 mln
Q3 Pretax Profit
$20.27 mln
Q3 Total Service Revenue
$522.87 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy"
Wall Street's median 12-month price target for RadNet Inc is $80.00, about 2.1% above its November 7 closing price of $78.31
The stock recently traded at 100 times the next 12-month earnings vs. a P/E of 110 three months ago
Press Release: ID:nGNX3HT9P4
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)